Search

Your search keyword '"Głuszko, Piotr"' showing total 163 results
Start Over Author "Głuszko, Piotr"
163 results on '"Głuszko, Piotr"'

1. Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry

Author

Drynda, Anna, primary, Padjas, Agnieszka, additional, Wójcik, Krzysztof, additional, Dziedzic, Radosław, additional, Biedroń, Grzegorz, additional, Wawrzycka-Adamczyk, Katarzyna, additional, Włudarczyk, Anna, additional, Wilańska, Joanna, additional, Musiał, Jacek, additional, Zdrojewski, Zbigniew, additional, Czuszyńska, Zenobia, additional, Masiak, Anna, additional, Majdan, Maria, additional, Jeleniewicz, Radosław, additional, Augustyniak-Bartosik, Hanna, additional, Jakuszko, Katarzyna, additional, Krajewska, Magdalena, additional, Dębska-Ślizień, Alicja, additional, Storoniak, Hanna, additional, Bułło-Piontecka, Barbara, additional, Tłustochowicz, Witold, additional, Kur-Zalewska, Joanna, additional, Wisłowska, Małgorzata, additional, Głuszko, Piotr, additional, Madej, Marta, additional, Jassem, Ewa, additional, Damps-Konstańska, Iwona, additional, Kucharz, Eugeniusz, additional, Brzosko, Marek, additional, Milchert, Marcin, additional, Hawrot-Kawecka, Anna, additional, Miłkowska-Dymanowska, Joanna, additional, Górski, Paweł, additional, Lewandowska-Polak, Anna, additional, Makowska, Joanna, additional, Zalewska, Joanna, additional, Zaręba, Lech, additional, and Bazan-Socha, Stanisława, additional

Published
2024
Full Text
View/download PDF

2. Treatment and its side effects in ANCA-associated vasculitides – Study based on POLVAS registry data

Author

Biedroń, Grzegorz, Włudarczyk, Anna, Wawrzycka-Adamczyk, Katarzyna, Wójcik, Krzysztof, Sznajd, Jan, Zdrojewski, Zbigniew, Masiak, Anna, Czuszyńska, Zenobia, Majdan, Maria, Jeleniewicz, Radosław, Klinger, Marian, Jakuszko, Katarzyna, Rowaiye, Olumide Olatubosun, Brzosko, Marek, Brzosko, Iwona, Dębska-Ślizień, Alicja, Storoniak, Hanna, Tłustochowicz, Witold, Kur-Zalewska, Joanna, Wisłowska, Małgorzata, Madej, Marta, Hawrot-Kawecka, Anna, Głuszko, Piotr, Kucharz, Eugeniusz J., Musiał, Jacek, and Szczeklik, Wojciech

Published
2020
Full Text
View/download PDF

5. Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022

Author

Głuszko, Piotr, primary, Sewerynek, Ewa, additional, Misiorowski, Waldemar, additional, Konstantynowicz, Jerzy, additional, Marcinowska-Suchowierska, Ewa, additional, Blicharski, Tomasz, additional, Jabłoński, Mirosław, additional, Franek, Edward, additional, Kostka, Tomasz, additional, Jaworski, Maciej, additional, Karczmarewicz, Elżbieta, additional, Kalinka, Ewa, additional, Księżopolska-Orłowska, Krystyna, additional, Więcek, Andrzej, additional, and Lorenc, Roman S., additional

Published
2023
Full Text
View/download PDF

8. Seasonally Dependent Change of the Number of Fractures after 50 Years of Age in Poland—Analysis of Combined Health Care and Climate Datasets

Author

Jedynasty, Kinga, primary, Zięba, Mariusz, additional, Adamski, Jakub, additional, Czech, Marcin, additional, Głuszko, Piotr, additional, Gozdowski, Dariusz, additional, Szypowska, Agnieszka, additional, Śliwczyński, Andrzej, additional, Walicka, Magdalena, additional, and Franek, Edward, additional

Published
2022
Full Text
View/download PDF

9. Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients

Author

Bonek, Krzysztof, primary, Kuca Warnawin, Ewa, additional, Kornatka, Anna, additional, Plebańczyk, Magdalena, additional, Burakowski, Tomasz, additional, Maśliński, Włodzimierz, additional, Wisłowska, Małgorzata, additional, Głuszko, Piotr, additional, and Ciechomska, Marzena, additional

Published
2022
Full Text
View/download PDF

10. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with the demographic and clinical characteristics of patients with ANCA-associated vasculitides

Author

Wójcik, Krzysztof, Masiak, Anna, Jeleniewicz, Radosław, Jakuszko, Katarzyna, Brzosko, Iwona, Storoniak, Hanna, Kur-Zalewska, Joanna, Wisłowska, Małgorzata, Madej, Marta, Hawrot-Kawecka, Anna, Głuszko, Piotr, and Kucharz, Eugeniusz J.

Subjects
Male, Myeloblastin, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Churg-Strauss Syndrome, urologic and male genital diseases, respiratory tract diseases, Antibodies, Antineutrophil Cytoplasmic, immune system diseases, Internal Medicine, Humans, Female, cardiovascular diseases, skin and connective tissue diseases, Demography
Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is characterized by the presence of proteinase‑3 (PR3) or myeloperoxidase (MPO) ANCA. In over 90% of cases, PR3‑ANCA is associated with granulomatosis with polyangiitis (GPA). However, it is also rarely found in microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). On the other hand, MPO‑ANCA being characteristic of MPA (90% of cases), is also found in about 40% of EGPA and 5% of GPA patients. On the ground of this overlap, clinical importance of ANCA specificity identification has been questioned.In this study, we analyzed the clinical and demographic characteristics of AAV subgroups identified by ANCA serotype.We conducted a multicenter study of AAV patients (417 GPA, 106 MPA, 102 EGPA; diagnosed between 1990 and 2016), included in the POLVAS registry. The data were systematically collected according to a standardized protocol.In the ANCA-positive group (anti‑MPO, anti‑PR3) a male-to-female ratio was 1:1, whereas in the ANCA-negative group it was 1:2, regardless of AAV diagnosis. Anti‑MPO antibodies were present in significantly older patients. Patients with MPO+GPA and MPO+EGPA were older than those with corresponding ANCA‑negative GPA and EGPA as well as PR3+AAV. Moreover, ANCA‑negative AAV was characterized by a low risk of end‑stage kidney disease and death.The presence and specificity of ANCA in AAV patients are related to sex and age, determine their organ involvement and influence mortality as previously shown. Patients with MPO‑ANCA-positive AAV constitute a clinically homogeneous group, whereas PR3‑ANCA-positive patients are much more clinically heterogeneous. ANCA-negative AAV patients are characterized by better prognosis. Thus, ANCA identification is an indispensable element and should not be omitted in establishing AAV diagnosis.

Published
2022

13. Acute Achilles tendon rupture after treatment with levofloxacin in a patient with giant cell arteritis

Author

Stasiek, Małgorzata and Głuszko, Piotr

Subjects
Achilles tendon, rupture, Case Report, tendinopathy, fluoroquinolones
Abstract

The authors report a case of a 67-year-old woman with giant cell arteritis with acute Achilles tendon rupture, which occurred after 3 days of levofloxacin therapy introduced because of newly diagnosed erosive gastritis associated with Helicobacter pylori infection. The Achilles tendon rupture was surgically treated and the patient made a complete recovery. In view of the widespread use of levofloxacin in practice, this case report raises important clinical implications. Tendinopathies are a known complication, quite rare in the healthy population, but the risk of rupture significantly increases in the population of patients over 60 years of age, with chronic usage of glucocorticosteroids, impaired renal function and recipients of organ transplants. What needs underlining, there are also described differences between individual fluoroquinolones as a cause of tendon damage in this group. Considering the widespread use of this group of drugs in patients, knowledge about the risk of adverse events including tendinopathy promotes safe use of fluoroquinolones.

Published
2019

21. Subphenotypes of ANCA-associated vasculitis identified by latent class analysis

Author

Wójcik, Krzysztof, primary, Biedroń, Grzegorz, additional, Wawrzycka-Adamczyk, Katarzyna, additional, Bazan-Socha, Stanisława, additional, Ćmiel, Adam, additional, Zdrojewski, Zbigniew, additional, Masiak, Anna, additional, Czuszyńska, Zenobia, additional, Majdan, Maria, additional, Jeleniewicz, Radosław, additional, Klinger, Marian, additional, Krajewska, Magdalena, additional, Kusztal, Mariusz, additional, Brzosko, Marek, additional, Iwona, Brzosko, additional, Dębska-Ślizień, Alicja, additional, Storoniak, Hanna, additional, Bułło-Piontecka, Barbara, additional, Tłustochowicz, Witold, additional, Kur-Zalewska, Joanna, additional, Wisłowska, Małgorzata, additional, Madej, Marta, additional, Hawrot-Kawecka, Anna, additional, Głuszko, Piotr, additional, Stasiek, Małgorzata, additional, Kucharz, Eugeniusz, additional, and Musiał, Jacek, additional

Published
2021
Full Text
View/download PDF

22. Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry

Author

Biedroń, Grzegorz, primary, Włudarczyk, Anna, additional, Wawrzycka-Adamczyk, Katarzyna, additional, Wójcik, Krzysztof, additional, Musiał, Jacek, additional, Bazan-Socha, Stanisława, additional, Zdrojewski, Zbigniew, additional, Masiak, Anna, additional, Czuszyńska, Zenobia, additional, Majdan, Maria, additional, Jeleniewicz, Radosław, additional, Klinger, Marian, additional, Krajewska, Magdalena, additional, Augustyniak-Bartosik, Hanna, additional, Jakuszko, Katarzyna, additional, Brzosko, Marek, additional, Brzosko, Iwona, additional, Dębska-Ślizień, Alicja, additional, Storoniak, Hanna, additional, Bułło-Piontecka, Barbara, additional, Tłustochowicz, Witold, additional, Kur-Zalewska, Joanna, additional, Wisłowska, Małgorzata, additional, Madej, Marta, additional, Hawrot-Kawecka, Anna, additional, Głuszko, Piotr, additional, Kucharz, Eugeniusz J., additional, and Szczeklik, Wojciech, additional

Published
2021
Full Text
View/download PDF

23. Inequities in access to biologic and synthetic DMARDs across 46 European countries

Author

Putrik, Polina, Ramiro, Sofia, Kvien, Tore K, Sokka, Tuulikki, Pavlova, Milena, Uhlig, Till, Boonen, Annelies, Tafaj, Argjent, Harutyunyan, Ruzanna, Radner, Helga, Soroka, Nikolay, Mielants, Herman, Sokolovic, Sekib, Lambova, Sevdalina, Mayer, Miroslav, Charalambous, Paraskevi, Vencovsky, Jiri, Hetland, Merete Lund, Peets, Tõnu, Fautrel, Bruno, Letsveridze, Khatuna, Müller-Ladner, Ulf, Sidiropoulos, Prodromos, Péntek, Márta, Gröndal, Gerdur, FitzGerald, Oliver, Bruno, Seriolo, Togizbayev, Galimzhan, Andersone, Daina, Butrimienė, Irena, Hirsch, Marco, Misevska-Percinkova, Snezana, Cassar, Karen, Deseatnicova, Elena, Mustur, Dusan, Głuszko, Piotr, Tavares, Viviana, Berghea, Florian, Shirinsky, Ivan, Veljkovic, Miodrag, Rovensky, Jozef, Tomsic, Matija, Sivera, Francisca, Petersson, Ingemar F., Axel, Finckh, Shaydullo, Sharipov, Inanc, Nevsun, Dumenko, Tatyana, Verstappen, Suzanne, and Khudoberdiev, Hojimurad

Published
2014
Full Text
View/download PDF

24. Osteoporoza

Author

Głuszko, Piotr, Tłustochowicz, Witold, and Goncerz, Grzegorz

Published
2020

25. Supplemental Material, Fig1s - Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases

Author

Kuca-Warnawin, Ewa, Janicka, Iwona, Szczęsny, Piotr, Olesińska, Marzena, Bonek, Krzysztof, Głuszko, Piotr, and Kontny, Ewa

Subjects
Medicine, Cell Biology
Abstract

Supplemental Material, Fig1s for Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases by Ewa Kuca-Warnawin, Iwona Janicka, Piotr Szczęsny, Marzena Olesińska, Krzysztof Bonek, Piotr Głuszko and Ewa Kontny in Cell Transplantation

Published
2020
Full Text
View/download PDF

28. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

Author

Meisters, Rachelle, primary, Putrik, Polina, additional, Ramiro, Sofia, additional, Hifinger, Monika, additional, Keszei, Andras P, additional, van Eijk-Hustings, Yvonne, additional, Woolf, Anthony D, additional, Smolen, Josef S, additional, Stamm, Tanja A, additional, Stoffer-Marx, Michaela, additional, Uhlig, Till, additional, Moe, Rikke Helene, additional, de Wit, Maarten, additional, Tafaj, Argjend, additional, Mukuchyan, Vahan, additional, Studenic, Paul, additional, Verschueren, Patrick, additional, Shumnalieva, Russka, additional, Charalambous, Paraskevi, additional, Vencovský, Jiří, additional, Varvouni, Melpomeni, additional, Kull, Mart, additional, Puolakka, Kari, additional, Gossec, Laure, additional, Gobejishvili, Nino, additional, Detert, Jacqueline, additional, Sidiropoulos, Prodromos, additional, Péntek, Márta, additional, Kane, David, additional, Scirè, Carlo Alberto, additional, Arad, Uri, additional, Andersone, Daina, additional, van de Laar, Mart, additional, van der Helm-van Mil, Annette, additional, Głuszko, Piotr, additional, Cunha-Miranda, Luís, additional, Berghea, Florian, additional, Damjanov, Nemanja S, additional, Tomšič, Matija, additional, Carmona, Loreto, additional, Turesson, Carl, additional, Ciurea, Adrian, additional, Shukurova, Surayo, additional, Inanc, Nevsun, additional, Verstappen, Suzanne MM, additional, and Boonen, Annelies, additional

Published
2020
Full Text
View/download PDF

30. Consensus Statement on the use of cyclosporin A in patients with severe keratitis in dry eye syndrome in ophthalmology, rheumatology and hematology*

Author

Borkowski, Leszek, primary, Dobrowolski, Dariusz, additional, Gil, Lidia, additional, Głuszko, Piotr, additional, Grabska-Liberek, Iwona, additional, Misiuk-Hojło, Marta, additional, Mrukwa-Kominek, Ewa, additional, Piekarska, Agnieszka, additional, Przeździecka-Dołyk, Joanna, additional, Romanowska-Dixon, Bożena, additional, Szaflik, Jacek P., additional, Targońska-Stępniak, Bożena, additional, Udziela, Monika, additional, and Wiland, Piotr, additional

Published
2020
Full Text
View/download PDF

36. Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis

Author

Kaczyński, Tomasz, primary, Wroński, Jakub, additional, Głuszko, Piotr, additional, Kryczka, Tomasz, additional, Miskiewicz, Andrzej, additional, Górski, Bartłomiej, additional, Radkowski, Marek, additional, Strzemecki, Damian, additional, Grieb, Paweł, additional, and Górska, Renata, additional

Published
2019
Full Text
View/download PDF

41. Guidelines for the diagnosis and management of osteoporosis in Poland : Update 2017

Author

Lorenc, Roman, primary, Głuszko, Piotr, additional, Franek, Edward, additional, Jabłoński, Mirosław, additional, Jaworski, Maciej, additional, Kalinka-Warzocha, Ewa, additional, Karczmarewicz, Elzbieta, additional, Kostka, Tomasz, additional, Księzopolska-Orłowska, Krystyna, additional, Marcinowska-Suchowierska, Ewa, additional, Misiorowski, Waldemar, additional, and Więcek, Andrzej, additional

Published
2017
Full Text
View/download PDF

42. Osteoporoza – spojrzenie w przeszłość

Author

Głuszko, Piotr

Subjects
osteoporotic fractures, lcsh:R, złamania osteoporotyczne, lcsh:Medicine, osteoporosis, osteoporoza
Abstract

Na różne formy osteoporozy ludzie chorowali od zawsze, ale nawet przed 100 laty był to jeszcze problem zdrowotny niewielkiej grupy osób - tych, które wyjątkowo dożywały sędziwego wieku lub też cierpiały na choroby, o których dziś wiemy, że powodują osteoporozy wtórne, ale w dawnych czasach praktycznie nieleczone, częściej były powodem zgonu niż złamań osteoporotycznych. W wieku XX, a zwłaszcza w jego drugiej połowie, nastąpiło znaczne wydłużenie średniego czasu życia oraz przyspieszenie postępu technologicznego i cywilizacyjnego. Osteoporoza jawi się jako poważny, narastający problem społeczny. Zostaje zauważona przez lekarzy również w Polsce. Niniejsze opracowanie jest próbą spojrzenia z polskiej perspektywy na postęp wiedzy i praktyki medycznej w tym zakresie. People have always got sick from various forms of osteoporosis, but even 100 years ago it was a health problem of a small group of people, i.e. those who lived to a very old age or suffered from diseases which are now known to cause secondary osteoporosis, but in the old days virtually untreated, diseases were causing death faster than osteoporotic fractures. The twentieth century, especially the second half, witnessed a significant lengthening of average lifespan, technological progress and civilization acceleration and now osteoporosis occurs as a serious, growing social problem. The problem is noticed by doctors all over the world, including Poland. This study is an attempt to look from the Polish perspective on the progress of medical knowledge and practice in this area.

Published
2011

43. Czynniki ryzyka upadków i złamań kości u pacjentów chorych na reumatoidalne zapalenie stawów

Author

Tomaszewski, Krzysztof, Chmielowska, Katarzyna, Zarychta, Magdalena, and Głuszko, Piotr

Subjects
rheumatoid arthritis, reumatoidalne zapalenie stawów, upadki, złamania kości, falls, lcsh:R, bone fractures, lcsh:Medicine
Abstract

Cel pracy: Ocena czynników ryzyka i częstości występowania upadków i złamań kości u chorych na reumatoidalne zapalenie stawów (RZS). Materiał i metody: Do badania kwalifikowano pacjentów chorych na RZS (spełniających kryteria ACR z 1984 r.). Dane na temat stanu zdrowia zebrano na podstawie ankiety zawierającej Kwestio - nariusz Oceny Stanu Zdrowia (HAQ), pytań dotyczących chorób, przyjmowanych leków, upadków i złamań kości w okresie ostatnich 12 miesięcy. Wyniki: Przebadano 167 kobiet (89,8%) i 19 mężczyzn (średni wiek ± SD 58,5 ±13,8 roku). Średni czas trwania choroby wynosił 14,4 ±10,7 roku. Średnia wartość HAQ 1,36 ±0,76. Z grupy 186 osób upadek przydarzył się 80 badanym (43%). U 28 chorych (35%) upadek zakończył się złamaniem bądź złamaniami obwodowymi. Liczba upadków dodatnio korelowała z wynikiem HAQ (r = 0,32; p < 0,05) oraz czasem trwania choroby (r = 0,31; p < 0,05). Głównymi czynnikami ryzyka upadków w badanej grupie były zawroty głowy [iloraz szans (OR) = 2,68], stosowanie leków hipotensyjnych (OR = 2,27) i przeciwdepresyjnych (OR = 2,56), deformacje stóp (OR = 3,14) oraz wysoki wskaźnik HAQ (OR = 2,08). Czas trwania RZS (OR = 1,05) i wiek (OR = 1,04) praktycznie nie wpływały na ryzyko upadków. Głównymi czynnikami ryzyka złamań kości w badanej grupie były osteoporoza (t-score < –2,5) (OR = 4,70), stosowanie leków hipotensyjnych (OR = 4,98), deformacje stóp (OR = 4,82), zawroty głowy (OR = 3,30) oraz wysoki wskaźnik HAQ (OR = 3,12). Wnioski: Upadki są poważnym problemem w przebiegu RZS. Głównymi czynnikami sprzyjającymi upadkom i złamaniom u chorych na RZS są deformacje stóp, zawroty głowy, zażywanie leków obniżających ciśnienie tętnicze oraz wysoka wartość HAQ. Objectives: To determine the one-year prevalence of falls and fractures in patients with rheumatoid arthritis (RA) and to evaluate the influence of potential risk factors on the occurrence of falls and bone fractures. Methods: The study enrolled 186 patients with RA (all fulfilling the ACR criteria). Patients were invited to complete an interviewerassisted questionnaire concerning falls and fractures in the previous 12 months and the health assessment questionnaire (HAQ). Patients’ history, clinical records and physical examination of 68 joints were assessed. Results: All patients completed the questionnaires (167 [89.8%] women and 19 men). The mean age was 58.5 ±13.8, the mean duration of RA was 14.4 ±10.7 years and the mean HAQ score was 1.36 ±0.76. Eighty patients (43%) reported falling one or more times. Among the “fallers”, 28 patients (35%) sustained one or more fractures as a result of a fall. Dizziness (odds ratio [OR] = 2.68), use of antidepressant (OR = 2.56) and antihypertensive drugs (OR = 2.27), foot deformities (OR = 3.14) and elevated HAQ scores (OR = 2.08) were noted as major risk factors for falls. There was no important increase in the frequency of falls with age or duration of RA. Among patients with fractures osteoporosis (t-score < –2.5) (OR = 4.70), antihypertensive medications (OR = 4.98), foot deformity (OR = 4.82), dizziness (OR = 3.30) and high HAQ scores (OR = 3.12) were identified as significant risk factors for fractures. Conclusions: Falls are common in RA patients. Foot deformities, dizziness, use of antihypertensive drugs and high HAQ scores were identified as major risk factors for falls and fractures.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results